Efficacy and $, page-9

We have some company for the IPO and we will be at an attractive price.

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of August 3:

Aimmune Therapeutics Inc. - Brisbane, Calif., 8.3 million shares, priced $14 to $16, managed by BofA Merrill Lynch, Credit Suisse, and Piper Jaffray. Proposed Nasdaq symbol AIMT. Business: Developing an oral immunotherapy designed to lessen the effects of peanut allergies.

Amplify Snack Brands Inc. - Austin, Texas, 15 million shares, priced $14 to $16, managed by Goldman Sachs, Jefferies, and Credit Suisse. Proposed NYSE symbol BETR. Business: PE-backed seller of SkinnyPop brand popcorn.

Benitec Biopharma Ltd. - Balmain, Australia, 5 million American depositary shares, each representing 20 ordinary shares, priced at $13, managed by BMO Capital Markets. Proposed Nasdaq symbol BNTC. Business: Developing gene therapies for hepatitis C based on RNA interference. Ordinary shares trade in Australia.

GC Aesthetics plc - Dublin, Ireland, 5.35 million ordinary shares, priced $13 to $15, managed by BofA Merrill Lynch, Deutsche Bank, and Cowen & Co. Proposed Nasdaq symbol GCAA. Business: Provider of silicone breast implants globally, outside the U.S.

Philadelphia Energy Solutions Inc. - Philadelphia, 15.15 million class A shares, priced $15 to $18, managed by BofA Merrill Lynch, Credit Suisse, and Goldman Sachs. Proposed NYSE symbol PESC. Business: Carlyle-backed owner of a crude oil refinery and rail terminal in Philadelphia.

Planet Fitness Inc. - Newington, N.H., 13.5 million class A shares, priced $14 to $16, managed by J.P. Morgan, BofA Merrill Lynch, and Jefferies. Proposed NYSE symbol PLNT. Business: Franchised low-cost gym chain with over 1,000 locations in the U.S.

Sunrun Inc. - San Francisco, 17.9 million shares, priced $13 to $15, managed by Credit Suisse, Goldman Sachs, and Morgan Stanley. Proposed Nasdaq symbol RUN. Business: Second-largest residential solar company in the U.S.

Zynerba Pharmaceuticals Inc. - Devon, Pa., 3 million shares, priced,$13 to $15, managed by Jefferies, and Piper Jaffray. Proposed Nasdaq symbol ZYNE. Business: Preclinical biotech developing cannabinoid-based therapies for osteoarthritis and epilepsy.